Prof Lonial talks to ecancertv at ASH 2015 about his study into the use of the monoclonal antibody daratumumab in patients with multiple myeloma.
This trial has led to the US FDA approval of daratumumab.
ecancer's filming at ASH 2015 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.
